Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
4.740
+0.220 (4.87%)
At close: May 12, 2025, 4:00 PM
4.970
+0.230 (4.85%)
After-hours: May 12, 2025, 4:37 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $71.20 million as of May 12, 2025. Its market cap has decreased by -78.57% in one year.
Market Cap
71.20M
Enterprise Value
-1.92M
1-Year Change
-78.57%
Ranking
Category
Stock Price
$4.74
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $71.20M, a decrease of -41.99%. That is a compound annual growth rate of -9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 67.90M | -78.83% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |